Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma (Q33710169)

28 July 2017

title

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma (English)

1 reference

neoplastic gene expression regulation

28 July 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

27 July 2024

Markus Hohenfellner

1 reference

28 July 2017

Felix Hoppe-Seyler

1 reference

28 July 2017

Karin Hoppe-Seyler

1 reference

28 July 2017

Nina Wagener

1 reference

Stephan Macher-Goeppinger

28 July 2017

series ordinal

object named as

Stephan Macher-Goeppinger

1 reference

28 July 2017

Maria Pritsch

1 reference

28 July 2017

Jesco Pfitzenmaier

1 reference

28 July 2017

Axel Haferkamp

1 reference

28 July 2017

Johannes Hüsing

1 reference

28 July 2017

Peter Schirmacher

series ordinal

1 reference

28 July 2017

language of work or name

English

0 references

publication date

4 October 2010

1 reference

full work available at URL

28 July 2017

https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

http://www.biomedcentral.com/1471-2407/10/524

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

http://www.biomedcentral.com/content/pdf/1471-2407-10-524.pdf

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

http://www.biomedcentral.com/1471-2407/10/524/abstract

27 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920340/pdf/?tool=EBI

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920340/?tool=EBI

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

https://europepmc.org/articles/PMC2958940

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

https://europepmc.org/articles/PMC2958940?pdf=render

27 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20920340

http://link.springer.com/content/pdf/10.1186/1471-2407-10-524.pdf

27 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

http://link.springer.com/article/10.1186/1471-2407-10-524/fulltext.html

27 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

http://link.springer.com/content/pdf/10.1186/1471-2407-10-524

27 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

https://link.springer.com/content/pdf/10.1186/1471-2407-10-524.pdf

27 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

27 July 2024

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

524

1 reference

28 July 2017

cites work

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Decoy receptor 3 is a prognostic factor in renal cell cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Genetics and epigenetics of renal cell cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

A polycomb repression signature in metastatic prostate cancer predicts cancer outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Sorafenib in advanced clear-cell renal-cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

The Polycomb group protein EZH2 directly controls DNA methylation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Rising incidence of renal cell cancer in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958940

Activated p53 suppresses the histone methyltransferase EZH2 gene

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

Identification of clinically useful cancer prognostic factors: what are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

Using protein expressions to predict survival in clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-524

Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20920340

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20920340

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20920340

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biochimica et Biophysica Acta

1785

133

MM Baldewijns

2008

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

The Cancer Journal from Scientific American

27 July 2024

RI Fisher

2000

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-524

27 July 2024

Identifiers

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference